LifeWatch Services, Inc. & LifeWatch AG announces the reinstatement of Cigna Corporation's coverage of mobile cardiac monitor...
October 16 2014 - 5:55PM
Business Wire
Release of an ad hoc announcement pursuant to Art. 53 KR
LifeWatch AG (SIX Swiss Exchange: LIFE), a leading provider of
medical solutions in remote cardiac monitoring, announces that
Cigna Corporation has reinstated coverage of the Ambulatory Cardiac
Telemetry (ACT) service provided by its subsidiary, LifeWatch
Services, Inc.
The coverage is retroactively effective as of June 15, 2014 and
applies to all Cigna affiliated entities.
In addition, the parties entered into a confidential settlement
agreement and LifeWatch Services, Inc. will be dismissing its
pending case filed in the U.S. District Court for the Eastern
District of Pennsylvania.
About LifeWatch AG: LifeWatch AG, headquartered in Neuhausen am
Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is
a leading healthcare technology and solution company, specializing
in advanced telehealth systems and wireless remote Patient
monitoring services. LifeWatch's services provide physicians with
critical information to determine appropriate treatment and thereby
improve Patient outcomes. LifeWatch AG has operative subsidiaries
in the United States, in Switzerland and in Israel, and is the
parent company of LifeWatch Services Inc., and LifeWatch
Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based
provider of cardiac monitoring services and home sleep testing of
Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based
in Israel, is a leading developer and manufacturer of telemedicine
products. For additional information, please visit
www.lifewatch.com.
Sign up for customized e-mail alerts and documentation requests
at http://www.irlifewatch.com/alert-service.aspx
This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results
of operations and financial position, the business strategy, and
plans and objectives for future operations, are forward-looking
statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar
expressions are intended to identify forward-looking statements.
LifeWatch AG has based these forward-looking statements largely on
current expectations and projections about future events and
financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and
long-term business operations and objectives, and financial needs.
These forward-looking statements are subject to a number of risks,
uncertainties and assumptions. In light of these risks,
uncertainties and assumptions, the forward-looking events and
circumstances described may not occur and actual results could
differ materially and adversely from those anticipated or implied
in the forward-looking statements. All forward-looking statements
are based only on data available to LifeWatch AG at the time of the
issue of this press release. LifeWatch AG does not undertake any
obligation to update any forward-looking statements contained in
this press release as a result of new information, future events or
otherwise.
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF
LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED
STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY
SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED
STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS
SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN
THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER
OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF
SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF
A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS
SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION
ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS
OF THE ISSUER.
For further questions:LifeWatch AG c/o Dynamics GroupPhilippe
Blangey / Doris Rudischhauser, +41 43 268 32
35investor-relations@lifewatch.com
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2023 to Apr 2024